Literature DB >> 28567510

[Atypical course of an apocrine sweat gland carcinoma of the axilla : A very rare malignant tumor and its interdisciplinary treatment].

U Wauer1, D Lorenz2, R Sellei3, E Zoga4, S Braun5.   

Abstract

We report on an atypical clinical course of a patient with the very rare diagnosis of an apocrine sweat gland carcinoma with lymphatic metastasis, a single metachronous distant metastasis and a now reached survival time of more than 4 years and give a review about the current literature. Only a very small number of cases have been described. The recommendations for diagnostics and treatment of this tumor, therefore, are not based on prospective randomized studies but upon case reports and on new immunohistochemical and genetic markers.

Entities:  

Keywords:  Bone metastasis; Diagnostics; Lymph node dissection; Neoplasm metastases; Therapy

Mesh:

Year:  2017        PMID: 28567510     DOI: 10.1007/s00105-017-4002-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  15 in total

Review 1.  [Sweat gland carcinomas of the skin].

Authors:  A Rütten; L Requena
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

2.  [Adnexal skin tumors].

Authors:  T Mentzel; A Rütten
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

3.  Metastatic cutaneous apocrine carcinoma of the axilla successfully treated using systemic chemotherapy with i.v. epirubicin and cyclophosphamide followed by oral fluorinated pyrimidine.

Authors:  Yasuhiro Fujisawa; Manabu Fujimoto
Journal:  J Dermatol       Date:  2014-02-10       Impact factor: 4.005

Review 4.  Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment.

Authors:  R S Chamberlain; K Huber; J C White; R Travaglino-Parda
Journal:  Am J Clin Oncol       Date:  1999-04       Impact factor: 2.339

Review 5.  Malignant sweat gland tumours: an update.

Authors:  José C Cardoso; Eduardo Calonje
Journal:  Histopathology       Date:  2015-07-21       Impact factor: 5.087

6.  Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas.

Authors:  K J Busam; L K Tan; S R Granter; S Kohler; J Junkins-Hopkins; M Berwick; P P Rosen
Journal:  Mod Pathol       Date:  1999-08       Impact factor: 7.842

7.  Management of Metastatic Apocrine Hidradenocarcinoma with Chemotherapy and Radiation.

Authors:  Daniel H Miller; Jennifer L Peterson; Steven J Buskirk; Laura A Vallow; Randy Ta; Richard Joseph; Murli Krishna; Stephen J Ko; Katherine S Tzou
Journal:  Rare Tumors       Date:  2015-10-05

8.  Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses.

Authors:  Long P Le; Dora Dias-Santagata; Amanda C Pawlak; Arjola K Cosper; Anh Thu Nguyen; M Angelica Selim; April Deng; Nora K Horick; A John Iafrate; Martin C Mihm; Mai P Hoang
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

9.  Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.

Authors:  Wilfred Truin; Rudi M H Roumen; Sabine Siesling; Koen K van de Vijver; Vivianne C G Tjan-Heijnen; Adri C Voogd
Journal:  Breast Cancer Res Treat       Date:  2017-04-01       Impact factor: 4.872

10.  Primary apocrine carcinoma of the axilla in a male patient: a case report.

Authors:  Rehan Zahid; Madiha E Soofi; Hind Elmalik; Kulsoom Junejo
Journal:  Clin Case Rep       Date:  2016-02-25
View more
  1 in total

Review 1.  A case of eccrine porocarcinoma characterized by a progressive increase in the level of Ki-67 index: case report and review of literature.

Authors:  Jie Shen; Xinfa Pan; Yongfu Lu; Desheng Pan; Yuehui Ma; Renya Zhan
Journal:  BMC Surg       Date:  2019-10-10       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.